the compound 2',3'-dideoxycytidine ( ddc ) is a potent inhibitor of human immunodeficiency virus replication in vitro and is currently in clinical trials for treatment of acquired immunodeficiency syndrome .
C0012132
dideoxycytidine
C0001175
acquired immunodeficiency syndrome